GRCE

Grace Therapeutics, Inc., based in Princeton, New Jersey, is an innovative pharmaceutical company committed to pioneering therapies for rare and orphan diseases. Leveraging cutting-edge research techniques and extensive clinical knowledge, Grace seeks to fulfill significant unmet medical needs both in Canada and globally. With a strong portfolio of specialized products in its pipeline, the company aims to improve patient outcomes and establish itself as a key player in the rare disease therapeutics market, reinforcing its position as a leader in this critical area of healthcare.